EUROFINS SCIENTIFIC (ESF0.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:ESF0 • FR0014000MR3

68.28 EUR
-0.14 (-0.2%)
Last: Feb 6, 2026, 07:00 PM
Fundamental Rating

5

Taking everything into account, ESF0 scores 5 out of 10 in our fundamental rating. ESF0 was compared to 19 industry peers in the Life Sciences Tools & Services industry. ESF0 has only an average score on both its financial health and profitability. ESF0 has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • ESF0 had positive earnings in the past year.
  • ESF0 had a positive operating cash flow in the past year.
  • ESF0 had positive earnings in each of the past 5 years.
  • Each year in the past 5 years ESF0 had a positive operating cash flow.
ESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFESF0.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • The Return On Assets of ESF0 (3.54%) is comparable to the rest of the industry.
  • The Return On Equity of ESF0 (8.09%) is better than 61.11% of its industry peers.
  • ESF0's Return On Invested Capital of 9.79% is fine compared to the rest of the industry. ESF0 outperforms 72.22% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ESF0 is in line with the industry average of 9.98%.
  • The 3 year average ROIC (8.70%) for ESF0 is below the current ROIC(9.79%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.54%
ROE 8.09%
ROIC 9.79%
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ESF0.DE Yearly ROA, ROE, ROICESF0.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • ESF0 has a Profit Margin (5.44%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of ESF0 has grown nicely.
  • ESF0 has a Operating Margin of 15.59%. This is comparable to the rest of the industry: ESF0 outperforms 50.00% of its industry peers.
  • ESF0's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 23.29%, ESF0 is doing worse than 83.33% of the companies in the same industry.
  • ESF0's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.59%
PM (TTM) 5.44%
GM 23.29%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
ESF0.DE Yearly Profit, Operating, Gross MarginsESF0.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ESF0 is still creating some value.
  • There is no outstanding debt for ESF0. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ESF0.DE Yearly Shares OutstandingESF0.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ESF0.DE Yearly Total Debt VS Total AssetsESF0.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 2.82 indicates that ESF0 is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ESF0 (2.82) is comparable to the rest of the industry.
  • The Debt to FCF ratio of ESF0 is 5.24, which is a neutral value as it means it would take ESF0, 5.24 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 5.24, ESF0 is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • ESF0 has a Debt/Equity ratio of 0.77. This is a neutral value indicating ESF0 is somewhat dependend on debt financing.
  • The Debt to Equity ratio of ESF0 (0.77) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 5.24
Altman-Z 2.82
ROIC/WACC1.1
WACC8.93%
ESF0.DE Yearly LT Debt VS Equity VS FCFESF0.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that ESF0 should not have too much problems paying its short term obligations.
  • ESF0's Current ratio of 1.26 is in line compared to the rest of the industry. ESF0 outperforms 50.00% of its industry peers.
  • A Quick Ratio of 1.19 indicates that ESF0 should not have too much problems paying its short term obligations.
  • ESF0 has a better Quick ratio (1.19) than 77.78% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.19
ESF0.DE Yearly Current Assets VS Current LiabilitesESF0.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 16.50% over the past year.
  • The Earnings Per Share has been growing by 18.34% on average over the past years. This is quite good.
  • ESF0 shows a small growth in Revenue. In the last year, the Revenue has grown by 2.53%.
  • Measured over the past years, ESF0 shows a quite strong growth in Revenue. The Revenue has been growing by 8.78% on average per year.
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%

3.2 Future

  • The Earnings Per Share is expected to grow by 15.68% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 7.25% on average over the next years.
EPS Next Y18.01%
EPS Next 2Y14.36%
EPS Next 3Y14.31%
EPS Next 5Y15.68%
Revenue Next Year5.1%
Revenue Next 2Y5.44%
Revenue Next 3Y5.93%
Revenue Next 5Y7.25%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ESF0.DE Yearly Revenue VS EstimatesESF0.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2B 4B 6B 8B
ESF0.DE Yearly EPS VS EstimatesESF0.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 18.97 indicates a rather expensive valuation of ESF0.
  • 72.22% of the companies in the same industry are more expensive than ESF0, based on the Price/Earnings ratio.
  • ESF0's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.92.
  • ESF0 is valuated correctly with a Price/Forward Earnings ratio of 16.90.
  • 72.22% of the companies in the same industry are more expensive than ESF0, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 27.78. ESF0 is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.97
Fwd PE 16.9
ESF0.DE Price Earnings VS Forward Price EarningsESF0.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 83.33% of the companies in the same industry are more expensive than ESF0, based on the Enterprise Value to EBITDA ratio.
  • ESF0's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ESF0 is cheaper than 88.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.85
EV/EBITDA 9.31
ESF0.DE Per share dataESF0.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • ESF0's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ESF0 has a very decent profitability rating, which may justify a higher PE ratio.
  • ESF0's earnings are expected to grow with 14.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.05
PEG (5Y)1.03
EPS Next 2Y14.36%
EPS Next 3Y14.31%

4

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.05%, ESF0 has a reasonable but not impressive dividend return.
  • ESF0's Dividend Yield is rather good when compared to the industry average which is at 0.41. ESF0 pays more dividend than 83.33% of the companies in the same industry.
  • With a Dividend Yield of 1.05, ESF0 pays less dividend than the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 1.05%

5.2 History

  • On average, the dividend of ESF0 grows each year by 16.51%, which is quite nice.
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
ESF0.DE Yearly Dividends per shareESF0.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

  • 54.88% of the earnings are spent on dividend by ESF0. This is a bit on the high side, but may be sustainable.
  • ESF0's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP54.88%
EPS Next 2Y14.36%
EPS Next 3Y14.31%
ESF0.DE Yearly Income VS Free CF VS DividendESF0.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
ESF0.DE Dividend Payout.ESF0.DE Dividend Payout, showing the Payout Ratio.ESF0.DE Dividend Payout.PayoutRetained Earnings

EUROFINS SCIENTIFIC

FRA:ESF0 (2/6/2026, 7:00:00 PM)

68.28

-0.14 (-0.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)01-29
Earnings (Next)07-21
Inst Owners35.61%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap12.44B
Revenue(TTM)6.89B
Net Income(TTM)375.00M
Analysts68.42
Price Target69.7 (2.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.05%
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP54.88%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.03%
PT rev (3m)4.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.91%
EPS NY rev (3m)2.83%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.32%
Valuation
Industry RankSector Rank
PE 18.97
Fwd PE 16.9
P/S 1.8
P/FCF 15.85
P/OCF 9.46
P/B 2.68
P/tB N/A
EV/EBITDA 9.31
EPS(TTM)3.6
EY5.27%
EPS(NY)4.04
Fwd EY5.92%
FCF(TTM)4.31
FCFY6.31%
OCF(TTM)7.22
OCFY10.57%
SpS37.84
BVpS25.45
TBVpS-3.69
PEG (NY)1.05
PEG (5Y)1.03
Graham Number45.4
Profitability
Industry RankSector Rank
ROA 3.54%
ROE 8.09%
ROCE 12.65%
ROIC 9.79%
ROICexc 10.74%
ROICexgc 34.11%
OM 15.59%
PM (TTM) 5.44%
GM 23.29%
FCFM 11.38%
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexgc growth 3Y-18.17%
ROICexgc growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score7
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 5.24
Debt/EBITDA 2.1
Cap/Depr 84.98%
Cap/Sales 7.7%
Interest Coverage 9.99
Cash Conversion 77.4%
Profit Quality 209.23%
Current Ratio 1.26
Quick Ratio 1.19
Altman-Z 2.82
F-Score7
WACC8.93%
ROIC/WACC1.1
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
EPS Next Y18.01%
EPS Next 2Y14.36%
EPS Next 3Y14.31%
EPS Next 5Y15.68%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
Revenue Next Year5.1%
Revenue Next 2Y5.44%
Revenue Next 3Y5.93%
Revenue Next 5Y7.25%
EBIT growth 1Y14.06%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year83.84%
EBIT Next 3Y29.91%
EBIT Next 5Y21.82%
FCF growth 1Y113.26%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y31.36%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%

EUROFINS SCIENTIFIC / ESF0.DE FAQ

What is the ChartMill fundamental rating of EUROFINS SCIENTIFIC (ESF0.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ESF0.DE.


What is the valuation status for ESF0 stock?

ChartMill assigns a valuation rating of 6 / 10 to EUROFINS SCIENTIFIC (ESF0.DE). This can be considered as Fairly Valued.


What is the profitability of ESF0 stock?

EUROFINS SCIENTIFIC (ESF0.DE) has a profitability rating of 6 / 10.


What are the PE and PB ratios of EUROFINS SCIENTIFIC (ESF0.DE) stock?

The Price/Earnings (PE) ratio for EUROFINS SCIENTIFIC (ESF0.DE) is 18.97 and the Price/Book (PB) ratio is 2.68.


How sustainable is the dividend of EUROFINS SCIENTIFIC (ESF0.DE) stock?

The dividend rating of EUROFINS SCIENTIFIC (ESF0.DE) is 4 / 10 and the dividend payout ratio is 54.88%.